ESR1 and breast cancer: Meanwhile, PIAS3 increased cyclin D1 expression in MCF-7 and T47D cells but inhibited the same in MDA-MB-231 and SKBR3 cells (Fig. 3a), suggesting that different effects of PIAS3 on breast cancer cells may be modulated by ER.